Dermapharm Holding SE
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMPHF research report →
About the company
Dermapharm Holding SE is an international pharmaceutical company specializing in off-patent branded medications, serving both domestic and global markets. Its business is structured across three distinct segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Imports, and Herbal Extracts. The company's comprehensive activities encompass the development, production, licensing, marketing, and distribution of its offerings.
- CEO
- Hans-Georg Feldmeier
- IPO
- 2022
- Employees
- 3,610
- HQ
- Grünwald, DE
Price Chart
- Market Cap
- $2.63B
- P/E
- 17.64
- P/S
- 2.01
- P/B
- 3.46
- EV/EBITDA
- 9.50
- Div Yield
- 1.85%
- Gross Margin
- 42.74%
- Op Margin
- 20.01%
- Net Margin
- 12.34%
- ROE
- 21.44%
- ROIC
- 8.55%
- Revenue
- $1.16B · -1.37%
- Net Income
- $132.36M · 16.32%
- EPS
- $2.46 · 16.59%
- Op Income
- $221.66M
- FCF YoY
- -14.59%
- 52W High
- $53.00
- 52W Low
- $39.56
- 50D MA
- $41.98
- 200D MA
- $40.16
- Beta
- 0.88
- Avg Volume
- 1
Get TickerSpark's AI analysis on DMPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our DMPHF coverage
Recent articles, reports, and earnings notes.
No research on DMPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DMPHF report →Similar companies
Peers in the same neighborhood.